Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Seizure suppression by adenosine-releasing cells is independent of seizure frequency
 
research article

Seizure suppression by adenosine-releasing cells is independent of seizure frequency

Boison, D.
•
Huber, A.
•
Padrun, V.
Show more
2002
Epilepsia

PURPOSE: Intraventricular cellular delivery of adenosine was recently shown to be transiently efficient in the suppression of seizure activity in the rat kindling model of epilepsy. We tested whether the suppression of seizures by adenosine-releasing grafts was independent of seizure frequency. METHODS: Adenosine-releasing cells were encapsulated and grafted into the lateral brain ventricle of rats kindled in the hippocampus. During 4 weeks after grafting, electric test stimulations were delivered at a frequency of either once a week or 3 times per week. Seizure activity was evaluated by visual scoring of seizure severity and by the recording of EEGs. RESULTS: Adenosine released from encapsulated cells exerted potent antiepileptic activity for >/=2 weeks. One week after grafting, treated rats displayed a complete protection from clonic seizures, and a protection from focal seizures was observed in the majority of animals. Seizure suppression was accompanied by a reduction of afterdischarges in EEG recordings. The protective efficacy of the grafted cells was the same irrespective of whether electrical test stimulations were delivered 1 or 3 times per week. Rats receiving control grafts continued to display full clonic convulsions. CONCLUSIONS: This study demonstrated that the frequency of test stimulations did not influence the seizure-suppressive potential of adenosine-releasing grafts. Thus the local delivery of adenosine is likely to be effective in seizure control over a threefold range of seizure-discharge frequency.

  • Details
  • Metrics
Type
research article
DOI
10.1046/j.1528-1157.2002.33001.x
Web of Science ID

WOS:000177383900002

Author(s)
Boison, D.
Huber, A.
Padrun, V.
Deglon, N.  
Aebischer, P.  
Mohler, H.
Date Issued

2002

Published in
Epilepsia
Volume

43

Issue

8

Start page

788

End page

96

Subjects

Adenosine/*administration & dosage/secretion/therapeutic use

•

Animals

•

Capsules

•

Cell Survival

•

Cell Transplantation/methods

•

Cerebral Ventricles

•

Cricetinae

•

Electroencephalography

•

Epilepsy/*drug therapy/etiology/physiopathology

•

Kidney/cytology/physiology/secretion

•

Kindling

•

Neurologic

•

Male

•

Rats

•

Rats

•

Inbred Strains

•

Rats

Note

Institute of Pharmacology and Toxicology, University of Zurich, Switzerland. boison@pharma.unizh.ch

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LEN  
Available on Infoscience
August 27, 2008
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/27536
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés